MSBIO, Inc.
0013Y0.KQ - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$216.81B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $216.81 Billion |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $- |
| Beta | 0 |
| Outstanding Shares | - |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About MSBIO, Inc.
CEO: Sungpo Kim
MS Bio, Inc. engages in the research and development of treatments for diseases using human tissue and biomaterials. Its products and services include the tissue bank and medical devices. The company was founded on October 27, 2015 and is headquartered in Seongnam-si, South Korea.